Latest News about ABBV
Recent news which mentions ABBV
Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna
August 27, 2024
From Benzinga
Donald Trump Owns These 21 Dividend Kings. Should You?
August 26, 2024
From Motley Fool
3 Unstoppable Dividend Stocks to Buy Right Now
August 25, 2024
From Motley Fool
From Benzinga
From Benzinga
3 High-Yield Stocks to Buy Now That Have Increased Their Dividends for 25 Years or More
August 18, 2024
From Motley Fool
These 3 Healthcare Companies Had the Top-Selling Drugs Last Year
August 18, 2024
From Motley Fool
3 High-Yielding Dividend Growth Stocks That Retirees Can Rely On for Recurring Income
August 17, 2024
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2024
From Benzinga
The 3 Best Stocks to Buy to Survive Another S&P 500 Crash
August 15, 2024
From InvestorPlace
Decoding AbbVie's Options Activity: What's the Big Picture?
August 14, 2024
Tickers
ABBV
From Benzinga
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
August 13, 2024
From Benzinga
From Benzinga
3 Stocks Retirees Should Absolutely Love
August 10, 2024
From Motley Fool
Warren Buffett's Approach To Investing In Election Years
August 07, 2024
From Benzinga
AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
August 06, 2024
From Benzinga
Worried About a Market Correction? 2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever.
August 05, 2024
From Motley Fool
From Benzinga
8 Health Care Stocks With Whale Alerts In Today's Session
August 01, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.